ArticleESMO real world data and digital oncology2025

Real-world safety and effectiveness data of trastuzumab deruxtecan and sacituzumab govitecan in breast cancer: a Hellenic Cooperative Oncology Group study.

E Fountzilas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.